Company intelligence / Profile preview

Napp Technologies

Lodi, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

Napp Technologies was a New Jersey-based manufacturer of active pharmaceutical ingredients (APIs) and bulk pharmaceutical chemicals. The company specialized in the production of high-quality chemical intermediates and finished APIs for the global pharmaceutical industry, operating as a contract manufacturing organization (CMO). It gained significant notoriety following a major industrial explosion at its Lodi facility in 1995, which led to extensive regulatory and legal scrutiny. In 1998, the company was acquired by Cambrex Corporation, which integrated Napp's manufacturing capabilities into its broader life sciences portfolio.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Napp Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Napp Technologies.

Explore the full profile